Kirkland Suffers Swift Defeat in Teva FDA Fight

, The Litigation Daily

   | 0 Comments

Less than a week after Teva Pharmaceutical Industries sued the FDA to block competitors from marketing generic versions of its blockbuster multiple sclerosis drug Copaxone, the company's lawyers are back where they started.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202655519595

Thank you!

This article's comments will be reviewed.